AGP Picks
View all

Vatican Technology Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Technology Review.

Press releases published on July 16, 2026

Cronos Group Inc. to Hold 2026 Second Quarter Earnings Conference Call on August 6, 2026
Plus Therapeutics and Genomic Testing Cooperative Partner to Integrate Next-Generation Sequencing Into the CNSide® CSF Assay Platform
Resignation of Director

Resignation of Director

Greenwich LifeSciences Announces European Approval for Combining Both HLA Populations in FLAMINGO-01
Arbutus Initiates International Patent Infringement Enforcement Actions Against Pfizer and BioNTech, Receives First Payment From Moderna Settlement Agreement and Announces Intent to Return Capital to Shareholders
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Aurora Mobile's EngageLab Partners with Mocasa: Building a Robust Security Foundation for Digital Credit with Advanced OTP Solutions
Adlai Nortye Announces First Patient Dosed in Intermittent Weekly Dosing Arm of Global Phase 1 Trial of Pan-RAS(ON) Inhibitor AN9025
Diagonal Therapeutics Announces First Patient Dosed in Phase 1/2 DIAMOND Clinical Trial of DIAG723 for Hereditary Hemorrhagic Telangiectasia (HHT)
Ragnarok: The New World Officially Launched in Southeast Asia on July 16, 2026
Traini Partners with Transsion to Bring Native Pet Emotion Translation to Smartphones
Denodo Platform 9.5 stellt agentenbasierter KI aktiven Kontext bereit, um effektiv und verantwortungsbewusst zu agieren
La plateforme Denodo 9.5 fournit un contexte actif à l’IA agentique pour une action efficace et responsable
Denodo Platform 9.5 Memperkasakan AI Berasaskan Ejen dengan Konteks Aktif, untuk Membolehkan Tindakan yang Berkesan dan Bertanggungjawab
Denodo Platform 9.5 為代理型 AI 提供主動情境,使其能負責任地有效行動
Japan Government, Industrial Leaders and NVIDIA Launch the World’s First National AI Infrastructure
Angelini Pharma Completes Acquisition of Catalyst Pharmaceuticals
Standard Chartered Selects Broadcom to Deliver Secure, Always-On Banking Services at Global Scale
Boehringer Ingelheim strengthens obesity pipeline as potential first-in-class triple receptor agonist BI 3034701 enters Phase II development
argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Vatican Technology Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.